The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism.

Irene Munk Pedersen, Anne Mette Buhl, Pia Klausen, Christian H Geisler, Jesper Jurlander

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

211 Citationer (Scopus)

Abstract

Udgivelsesdato: 2002-Feb-15
OriginalsprogEngelsk
TidsskriftBlood
Vol/bind99
Udgave nummer4
Sider (fra-til)1314-9
Antal sider5
ISSN0006-4971
StatusUdgivet - 2002
Udgivet eksterntJa

Bibliografisk note

Keywords: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Agents; Apoptosis; Enzyme Activation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Tumor Cells, Cultured; p38 Mitogen-Activated Protein Kinases

Citationsformater